Published in Clin Diagn Lab Immunol on March 01, 1996
IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines. AIDS Res Hum Retroviruses (2010) 1.18
The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism. Infect Immun (2006) 1.11
Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. Proc Natl Acad Sci U S A (1999) 1.08
Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein. Retrovirology (2006) 1.05
HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia. J Thromb Haemost (2011) 0.87
A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice. Proc Natl Acad Sci U S A (2002) 0.84
The grafting of universal T-helper epitopes enhances immunogenicity of HIV-1 Tat concurrently improving its safety profile. PLoS One (2014) 0.77
Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques. Virol J (2016) 0.75
Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort. BMC Infect Dis (2016) 0.75
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature (1994) 3.05
Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 2.16
Regulation of HIV-1 gene expression. FASEB J (1991) 2.01
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.10
Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo. J Med Virol (1988) 1.09
Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1. J Med Virol (1990) 1.05
Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status. Blood (1987) 1.01
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals. J Acquir Immune Defic Syndr (1991) 0.92
Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch Virol (1994) 0.88
Protein content and factor VIII complex in untreated, treated and monoclonal factor VIII concentrates. Thromb Res (1989) 0.81
Is the apparent outbreak of hepatitis A in Belgian hemophiliacs due to a loss of previous passive immunity? Vox Sang (1994) 0.81
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood (1999) 2.10
Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. J Med Virol (1985) 2.09
Serum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections detected by ELISA and an immunofluorescence test. J Clin Pathol (1984) 1.46
Selective inhibition of a nuclear RNA polymerase in cells infected with frog virus. Nature (1970) 1.44
Parvovirus b19 DNA is commonly harboured in human skin. Dermatology (2010) 1.41
Acute depression from isotretinoin. Another case. J Eur Acad Dermatol Venereol (2005) 1.38
Human cytomegalovirus structural components: intracellular and intraviral localization of p28 and p65-69 by immunoelectron microscopy. Virus Res (1987) 1.38
Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Trans R Soc Trop Med Hyg (1975) 1.29
Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans. J Virol (1997) 1.27
Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis. J Gen Virol (1989) 1.26
HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res (1998) 1.21
Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection. J Clin Microbiol (1989) 1.20
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. Cell Mol Life Sci (2004) 1.19
Chlamydial infections in Italy. Sex Transm Dis (1982) 1.18
Partial characterization of an 89-kDa highly immunoreactive protein from Chlamydia psittaci A/22 causing ovine abortion. FEMS Microbiol Lett (1991) 1.16
Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. J Immunol (1999) 1.16
Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection. Microbiol Immunol (1986) 1.12
Prevalence in Italy of antibodies to a new human papovavirus (BK virus). J Med Microbiol (1974) 1.11
Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res (1993) 1.11
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.10
Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients. J Clin Virol (2001) 1.08
TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood (2000) 1.08
Studies on mediterranean Leishmaniasis. I. An outbreak of visceral leishmaniasis in Northern Italy. Trans R Soc Trop Med Hyg (1974) 1.07
Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.07
Ultrastructural aspects of BK virus uptake and replication in human fibroblasts. J Gen Virol (1975) 1.04
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. Mini Rev Med Chem (2011) 1.04
Effect of human immunodeficiency virus infection on haematopoiesis. Baillieres Clin Haematol (1995) 1.04
Evaluation of immunoassays for the detection and typing of PCR amplified human papillomavirus DNA. J Clin Pathol (1998) 1.04
Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis (1988) 1.02
Ribonucleic acid polymerase induced by vaccinia virus: lack of inhibition by rifampicin and alpha-amanitin. J Virol (1970) 1.01
Antigenic specificity of serological response in Chlamydia trachomatis urethritis detected by immunoblotting. J Clin Pathol (1986) 1.00
Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway. J Leukoc Biol (2001) 0.99
Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation (1995) 0.98
Rapid screening for B19 parvovirus DNA in clinical specimens with a digoxigenin-labeled DNA hybridization probe. J Clin Microbiol (1990) 0.97
Enzyme-linked immunosorbent assay for the in-vitro detection of sensitivity of Chlamydia trachomatis to antimicrobial drugs. J Antimicrob Chemother (1987) 0.97
Optimal detection of apoptosis by flow cytometry depends on cell morphology. Cytometry (1993) 0.97
HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis. AIDS Res Hum Retroviruses (1995) 0.96
Prevalence of enteric adenovirus from acute gastroenteritis: a five year study. Eur J Epidemiol (1987) 0.96
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. Br J Haematol (1995) 0.96
Evidence for a human immunodeficiency virus type 1-mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J Infect Dis (1992) 0.96
Inactivation of polykaryocytogenic and hemolytic activities of Sendai virus by phospholipase B (lysolecithinase). J Virol (1971) 0.95
Impairment of cytomegalovirus and host balance in elderly subjects. J Clin Pathol (1988) 0.95
Effect of heat shock on Epstein-Barr virus and cytomegalovirus expression. J Gen Virol (1985) 0.95
Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. Eur J Immunol (1997) 0.95
Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1. Arch Virol (1994) 0.95
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents. Mini Rev Med Chem (2009) 0.94
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients. Oncol Rep (2006) 0.94
Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS (1993) 0.94
A hybrido-immunocytochemical assay for the in situ detection of cytomegalovirus DNA using digoxigenin-labeled probes. J Immunol Methods (1989) 0.92
Comparison of the immune response to Epstein-Barr virus and cytomegalovirus in sera and synovial fluids of patients with rheumatoid arthritis. Ann Rheum Dis (1987) 0.92
[Research on the mechanism of cytopathogenic action of alpha-amanitine]. Sperimentale (1967) 0.92
Studies on Mediterranean leishmaniasis. IV. The leishmanin skin test in cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1976) 0.92
Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells. AIDS (1999) 0.92
Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-beta 1 mRNA expression and protein synthesis in peripheral blood monocytes. Br J Haematol (1994) 0.92
Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood (1992) 0.92
In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell line. Blood (1994) 0.91
Impairment of herpesvirus growth in chick embryo fibroblast cultures by -amanitin. Brief report. Arch Gesamte Virusforsch (1971) 0.91
Alkaline phosphatase immunoenzymatic staining for detection of antigens induced by cytomegalovirus. J Clin Pathol (1985) 0.90
Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes. Anat Rec (2000) 0.90
Involvement of the pathway phosphatidylinositol-3-kinase/AKT-1 in the establishment of the survival response to ionizing radiation. Cell Signal (2001) 0.90
In situ detection of cytomegalovirus DNA in biopsies of AIDS patients using a hybrido-immunocytochemical assay. Histochemistry (1990) 0.90
In vitro infection of human epidermal Langerhans' cells with HIV-1. Immunology (1995) 0.89
TRAIL-based therapeutic approaches for the treatment of pediatric malignancies. Curr Med Chem (2013) 0.89
A 28000 molecular weight human cytomegalovirus structural polypeptide studied by means of a specific monoclonal antibody. J Gen Virol (1985) 0.89
A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type 1. Blood (1994) 0.88
Detection of specific immunoglobulin M antibodies to cytomegalovirus by using monoclonal antibody to immunoglobulin M in an indirect immunofluorescence assay. J Clin Microbiol (1986) 0.88
Acylated proteins in Borrelia hermsii, Borrelia parkeri, Borrelia anserina, and Borrelia coriaceae. Appl Environ Microbiol (1993) 0.88
Modifications of cellular RNA-polymerase II after infection with frog virus 3. J Gen Virol (1975) 0.88
Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia. Cytometry (2001) 0.88
Class specific immunoglobulin response to individual polypeptides of Chlamydia trachomatis, elementary bodies, and reticulate bodies in patients with chlamydial infection. J Clin Pathol (1986) 0.88
Dot immunoperoxidase assay using monoclonal antibody for direct detection of cytomegalovirus in urine samples. J Clin Microbiol (1987) 0.87